Leslie Lilly

3.3k total citations
83 papers, 1.9k citations indexed

About

Leslie Lilly is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Leslie Lilly has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 42 papers in Epidemiology and 31 papers in Surgery. Recurrent topics in Leslie Lilly's work include Liver Disease and Transplantation (38 papers), Liver Disease Diagnosis and Treatment (38 papers) and Organ Transplantation Techniques and Outcomes (28 papers). Leslie Lilly is often cited by papers focused on Liver Disease and Transplantation (38 papers), Liver Disease Diagnosis and Treatment (38 papers) and Organ Transplantation Techniques and Outcomes (28 papers). Leslie Lilly collaborates with scholars based in Canada, United States and United Kingdom. Leslie Lilly's co-authors include Mark S. Cattral, Paul D. Greig, Eberhard L. Renner, Gary Levy, Nazia Selzner, George Therapondos, Markus Selzner, Ian D. McGilvray, David Grant and Mamatha Bhat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Leslie Lilly

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie Lilly Canada	25	1.3k	925	786	384	260	83	1.9k
Jeffrey B. Halldorson United States	15	883 0.7×	1.0k 1.1×	709 0.9×	322 0.8×	262 1.0×	30	1.6k
George E. Loss United States	21	919 0.7×	790 0.9×	591 0.8×	291 0.8×	244 0.9×	51	1.5k
Lisa Forman United States	20	2.1k 1.6×	943 1.0×	1.6k 2.0×	211 0.5×	177 0.7×	47	2.6k
Curtis Holt United States	26	2.5k 1.9×	1.5k 1.6×	1.9k 2.5×	734 1.9×	213 0.8×	46	3.3k
G. Gubernatis Germany	21	1.4k 1.1×	1.5k 1.7×	558 0.7×	245 0.6×	402 1.5×	89	2.1k
G. Blumhardt Germany	23	1.3k 1.0×	1.2k 1.3×	627 0.8×	605 1.6×	129 0.5×	99	2.2k
Jeffery L. Steers United States	29	1.3k 1.0×	1.1k 1.2×	1.0k 1.3×	326 0.8×	94 0.4×	64	2.3k
S. Agnes Italy	22	1.2k 0.9×	886 1.0×	774 1.0×	267 0.7×	102 0.4×	102	1.7k
C. E. Broelsch Germany	20	1.2k 0.9×	1.4k 1.5×	367 0.5×	177 0.5×	583 2.2×	80	1.8k
Aiman Obed Germany	18	1.1k 0.8×	1.0k 1.1×	463 0.6×	267 0.7×	144 0.6×	75	1.8k

Countries citing papers authored by Leslie Lilly

Since Specialization

Citations

This map shows the geographic impact of Leslie Lilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Lilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Lilly more than expected).

Fields of papers citing papers by Leslie Lilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Lilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Lilly. The network helps show where Leslie Lilly may publish in the future.

Co-authorship network of co-authors of Leslie Lilly

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Lilly. A scholar is included among the top collaborators of Leslie Lilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Lilly. Leslie Lilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirode, Grishma, Mamatha Bhat, Leslie Lilly, et al.. (2025). Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation. Journal of Viral Hepatitis. 32(6). e70031–e70031. 1 indexed citations

Azhie, Amirhossein, Shiyi Chen, Wei Xu, et al.. (2024). Long-Term Survival of Canadian Liver Transplant Recipients Remains Stagnant— A Cohort Study on the Evolution of Cause-Specific Mortality. Digestive Diseases and Sciences. 70(2). 543–551. 1 indexed citations

Chen, Shiyi, Wei Xu, Keyur Patel, et al.. (2023). Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis. Hepatology Communications. 7(8). 7 indexed citations

Azhie, Amirhossein, Shiyi Chen, Wei Xu, et al.. (2023). Impact of living donor liver transplantation on long‐term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis. Clinical Transplantation. 37(9). e15008–e15008. 1 indexed citations

Chen, Shiyi, Catherine Chen, Wei Xu, et al.. (2023). Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients. Aging. 15(17). 8594–8612. 4 indexed citations

Shwaartz, Chaya, Blayne A. Sayed, Gonzalo Sapisochín, et al.. (2023). Should advanced donor age be a deterrent in the utilization of grafts from donation after cardiac death in deceased donor liver transplantation? The Toronto experience. Canadian Journal of Surgery. 66(6). E561–E571.

Chen, Catherine, Shiyi Chen, Amirhossein Azhie, et al.. (2022). Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study. World Journal of Gastroenterology. 28(26). 3218–3231. 3 indexed citations

Bilodeau, Marc, Bandar Al‐Judaibi, Eric M. Yoshida, et al.. (2018). Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study. PubMed. 17(1). 59–63. 4 indexed citations

Aravinthan, Aloysious, Adam Doyle, Hla‐Hla Thein, et al.. (2017). Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma. Annals of Surgical Oncology. 24(7). 1843–1851. 16 indexed citations

10.

Tanaka, Tomohiro, Eberhard L. Renner, Nazia Selzner, George Therapondos, & Leslie Lilly. (2013). The Impact of Obesity as Determined by Modified Body Mass Index on Long-Term Outcome After Liver Transplantation: Canadian Single-Center Experience. Transplantation Proceedings. 45(6). 2288–2294. 28 indexed citations

11.

Ghanekar, Anand, A. Kashfi, Mark S. Cattral, et al.. (2012). Routine Induction Therapy in Living Donor Liver Transplantation Prevents Rejection but May Promote Recurrence of Hepatitis C. Transplantation Proceedings. 44(5). 1351–1356. 10 indexed citations

12.

Tanaka, Tomohiro, Nazia Selzner, George Therapondos, Eberhard L. Renner, & Leslie Lilly. (2012). Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients. Transplant International. 26(1). 42–49. 13 indexed citations

13.

Adcock, Lesley, Derek A. DuBay, Paul D. Greig, et al.. (2010). Adult Living Liver Donors have Excellent Long-Term Medical Outcomes: The University of Toronto Liver Transplant Experience. American Journal of Transplantation. 10(2). 364–371. 81 indexed citations

14.

Madill, Janet, Bianca M. Arendt, Elaheh Aghdassi, et al.. (2010). Oxidative Stress and Nutritional Factors in Hepatitis C Virus–Positive Liver Recipients, Controls, and Hepatitis C Virus–Positive Nontransplant Patients. Transplantation Proceedings. 42(5). 1744–1749. 5 indexed citations

15.

Selzner, Nazia, Eberhard L. Renner, Markus Selzner, et al.. (2009). Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term Outcome. Transplantation. 88(10). 1214–1221. 87 indexed citations

16.

Madill, Janet, Bianca M. Arendt, Elaheh Aghdassi, et al.. (2009). Hepatic Lipid Peroxidation and Antioxidant Micronutrients in Hepatitis Virus C Liver Recipients With and Without Disease Recurrence. Transplantation Proceedings. 41(9). 3800–3805. 8 indexed citations

17.

Ramji, Alnoor, Vincent G. Bain, Mang Ma, et al.. (2005). Transplant immunosuppressive agents in non‐transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver International. 25(4). 723–727. 87 indexed citations

18.

Shah, Shimul A., David Grant, Paul D. Greig, et al.. (2005). Analysis and Outcomes of Right Lobe Hepatectomy in 101 Consecutive Living Donors. American Journal of Transplantation. 5(11). 2764–2769. 64 indexed citations

19.

Hemming, Alan W., et al.. (1998). A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in Canada. Clinical Transplantation. 12(5). 425–429. 4 indexed citations

20.

Hemming, Alan W., Paul D. Greig, Mark S. Cattral, et al.. (1997). Neoral without intravenous cyclosporine in liver transplantation. Transplantation Proceedings. 29(1-2). 543–543. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact